Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (2z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)prop-2-enehydrazide
2. 2-propenoic Acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-, 2-(2-pyridinyl)hydrazide, (2z)-
3. Kpt-335
4. Kpt335
1. 1392136-43-4
2. Verdinexor (kpt-335)
3. Kpt-335
4. 85q03215iw
5. (z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)acrylohydrazide
6. (2z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)prop-2-enehydrazide
7. 2-propenoic Acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-, 2-(2-pyridinyl)hydrazide, (2z)-
8. Kpt335
9. (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyridin-2-ylprop-2-enehydrazide
10. Verdinexor [usan:inn]
11. Unii-85q03215iw
12. Verdinexor [inn]
13. Kpt335;verdinexor
14. Verdinexor (usan/inn)
15. Verdinexor [usan]
16. Chembl3545187
17. Schembl14678337
18. Ex-a871
19. Kpt 335
20. Dtxsid301022535
21. Bcp11733
22. S7707
23. Zinc205957597
24. Ccg-269150
25. Db12207
26. Ncgc00386421-08
27. Ac-32682
28. Bs-15021
29. D11223
30. J-690155
31. Q27269660
32. 2-[(5-chloro-2-{[4-(1-piperazinyl)phenyl]amino}-4-pyrimidinyl)amino]-n-methylbenzamide
33. (z)-3-(3-(3,5-bis-(trifluoromethyl)phenyl)-1h-1,2,4-triazol-1-yl)-n'-(pyridin-2-yl)acrylohydrazide
34. 1656285-28-7
Molecular Weight | 442.3 g/mol |
---|---|
Molecular Formula | C18H12F6N6O |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 5 |
Exact Mass | 442.09767800 g/mol |
Monoisotopic Mass | 442.09767800 g/mol |
Topological Polar Surface Area | 84.7 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 620 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
48
PharmaCompass offers a list of Verdinexor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Verdinexor manufacturer or Verdinexor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Verdinexor manufacturer or Verdinexor supplier.
PharmaCompass also assists you with knowing the Verdinexor API Price utilized in the formulation of products. Verdinexor API Price is not always fixed or binding as the Verdinexor Price is obtained through a variety of data sources. The Verdinexor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Verdinexor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Verdinexor, including repackagers and relabelers. The FDA regulates Verdinexor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Verdinexor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Verdinexor supplier is an individual or a company that provides Verdinexor active pharmaceutical ingredient (API) or Verdinexor finished formulations upon request. The Verdinexor suppliers may include Verdinexor API manufacturers, exporters, distributors and traders.
click here to find a list of Verdinexor suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Verdinexor as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Verdinexor API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Verdinexor as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Verdinexor and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Verdinexor NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Verdinexor suppliers with NDC on PharmaCompass.
Verdinexor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Verdinexor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Verdinexor GMP manufacturer or Verdinexor GMP API supplier for your needs.
A Verdinexor CoA (Certificate of Analysis) is a formal document that attests to Verdinexor's compliance with Verdinexor specifications and serves as a tool for batch-level quality control.
Verdinexor CoA mostly includes findings from lab analyses of a specific batch. For each Verdinexor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Verdinexor may be tested according to a variety of international standards, such as European Pharmacopoeia (Verdinexor EP), Verdinexor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Verdinexor USP).